Discontinued GSK asthma drug stirs frustrations

After GSK discontinued its brand-name asthma drug Flovent on Jan. 1, families and physicians are struggling to access its generic solution, CNN reported Feb. 13.

The drugmaker is still selling the generic, fluticasone, but patients are scrambling to access it because some payers cover only the branded version. Alternative therapies are also hard to come by, and some of the alternatives covered on formularies are not appropriate for young children.